GateBio: Gate: selective blockade of pathogenic protein secretion

NOV 02, 2023 | 2:10 PM PDT | BIOCENTURY | EMERGING COMPANY PROFILEGATE: SELECTIVE BLOCKADE OF PATHOGENIC PROTEIN SECRETIONBY Gate Bio emerged from stealth with a $60M series A and a small molecule platform for selective gating of protein secretionhttps://www.biocentury.com/article/650493/gate-selective-blockade-of-pathogenic-protein-secretion© 2023 BioCentury Inc. All Rights Reserved